Analyze Diet

How to perform transvenous electrical cardioversion in horses with atrial fibrillation.

Abstract: Electrical cardioversion of atrial fibrillation is a well-established technique for restoration of sinus rhythm in humans. While transthoracic cardioversion is more commonly used, transvenous electrical cardioversion (TVEC) has been reported as having higher efficacy at substantially lower energy levels. In horses, treatment of atrial fibrillation has essentially been limited to the administration of quinidine salts either orally or intravenously. TVEC provides an alternative to quinidine salts, especially for those animals in which quinidine is neither effective nor tolerated. The present report details this technique in horses, discusses possible complications of the procedure, and provides guidance for successful outcome. Still and video images are used to illustrate details with regard to TVEC techniques in horses. Please view supplemental material for the videos.
Publication Date: 2005-11-15 PubMed ID: 19083326DOI: 10.1016/j.jvc.2005.09.001Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article focuses on a more effective treatment for atrial fibrillation in horses, called transvenous electrical cardioversion (TVEC), which was previously only commonly used in humans.

Introduction

  • The traditional treatment for atrial fibrillation in horses has been the administration of quinidine salts, either orally or intravenously.
  • However, there may be instances where this treatment is not effective or is not well-tolerated by the horse. This has prompted researchers to look for alternative treatments.
  • Transvenous electrical cardioversion (TVEC) has been identified as one such alternative. This treatment method, while more commonly used in humans, is reported to have higher efficacy while using substantially lower energy levels in horses.

Procedure

  • The research article not only details how to perform TVEC in horses but also discusses potential complications that may arise during the procedure.
  • The aim is to provide guidance to veterinarians and other professionals so they can successfully treat horses using this method.
  • Still and video images are also included in the research to help illustrate the TVEC procedure in horses. These documents serve as additional resources for guidance and reference.

Conclusion

  • TVEC offers a potentially more effective and safer treatment option for horses suffering from atrial fibrillation, especially in cases where traditional methods are ineffective or not tolerated.
  • The research article thus provides a comprehensive guide for performing the procedure, highlighting its benefits and potential complications. This is expected to help animal health professionals in implementing this technique with greater confidence and success.

Cite This Article

APA
McGurrin MK, Physick-Sheard PW, Kenney DG. (2005). How to perform transvenous electrical cardioversion in horses with atrial fibrillation. J Vet Cardiol, 7(2), 109-119. https://doi.org/10.1016/j.jvc.2005.09.001

Publication

ISSN: 1875-0834
NlmUniqueID: 101163270
Country: Netherlands
Language: English
Volume: 7
Issue: 2
Pages: 109-119

Researcher Affiliations

McGurrin, M Kimberly J
  • Veterinary Teaching Hospital, Ontario Veterinary College, University of Guelph, Guelph, Ontario, N1G 2W1, Canada.
Physick-Sheard, Peter W
    Kenney, Daniel G

      Citations

      This article has been cited 11 times.
      1. Kuroda T, Minamijima Y, Kinman CK, Takahashi Y, Ebisuda Y, Inoue K, Ishikawa H, Mita H, Tamura N, Nukada T, Toutain PL, Ohta M. Rational quinidine dosage regimen for atrial fibrillation in Thoroughbred racehorses based on population pharmacokinetics. Front Vet Sci 2024;11:1454342.
        doi: 10.3389/fvets.2024.1454342pubmed: 39439824google scholar: lookup
      2. Carstensen H, Nissen SD, Saljic A, Hesselkilde EM, van Hunnik A, Hohl M, Sattler SM, Fløgstad C, Hopster-Iversen C, Verheule S, Böhm M, Schotten U, Jespersen T, Buhl R. Long-Term Training Increases Atrial Fibrillation Sustainability in Standardbred Racehorses. J Cardiovasc Transl Res 2023 Oct;16(5):1205-1219.
        doi: 10.1007/s12265-023-10378-6pubmed: 37014465google scholar: lookup
      3. Kjeldsen ST, Nissen SD, Buhl R, Hopster-Iversen C. Paroxysmal Atrial Fibrillation in Horses: Pathophysiology, Diagnostics and Clinical Aspects. Animals (Basel) 2022 Mar 10;12(6).
        doi: 10.3390/ani12060698pubmed: 35327097google scholar: lookup
      4. Vernemmen I, Van Steenkiste G, Dufourni A, Decloedt A, van Loon G. Transvenous electrical cardioversion of atrial fibrillation in horses: Horse and procedural factors correlated with success and recurrence. J Vet Intern Med 2022 Mar;36(2):758-769.
        doi: 10.1111/jvim.16395pubmed: 35246994google scholar: lookup
      5. Broux B, De Clercq D, Vera L, Ven S, Deprez P, Decloedt A, van Loon G. Can heart rate variability parameters derived by a heart rate monitor differentiate between atrial fibrillation and sinus rhythm?. BMC Vet Res 2018 Oct 25;14(1):320.
        doi: 10.1186/s12917-018-1650-6pubmed: 30359273google scholar: lookup
      6. McGurrin MKJ. The diagnosis and management of atrial fibrillation in the horse. Vet Med (Auckl) 2015;6:83-90.
        doi: 10.2147/VMRR.S46304pubmed: 30101098google scholar: lookup
      7. Kraus M, Physick-Sheard P, Brito LF, Sargolzaei M, Schenkel FS. Marginal ancestral contributions to atrial fibrillation in the Standardbred racehorse: Comparison of cases and controls. PLoS One 2018;13(5):e0197137.
        doi: 10.1371/journal.pone.0197137pubmed: 29763439google scholar: lookup
      8. Marly-Voquer C, Schwarzwald CC, Bettschart-Wolfensberger R. The use of dexmedetomidine continuous rate infusion for horses undergoing transvenous electrical cardioversion--A case series. Can Vet J 2016 Jan;57(1):70-5.
        pubmed: 26740702
      9. Bozorgmanesh R, Magdesian KG, Estell KE, Stern JA, Swain EA, Griffiths LG. Atrial Fibrillation in Eight New World Camelids. J Vet Intern Med 2016 Jan-Feb;30(1):335-8.
        doi: 10.1111/jvim.13798pubmed: 26647783google scholar: lookup
      10. Reef VB, Bonagura J, Buhl R, McGurrin MK, Schwarzwald CC, van Loon G, Young LE. Recommendations for management of equine athletes with cardiovascular abnormalities. J Vet Intern Med 2014 May-Jun;28(3):749-61.
        doi: 10.1111/jvim.12340pubmed: 24628586google scholar: lookup
      11. De Clercq D, Decloedt A, Sys SU, Verheyen T, Van Der Vekens N, van Loon G. Atrial fibrillation cycle length and atrial size in horses with and without recurrence of atrial fibrillation after electrical cardioversion. J Vet Intern Med 2014 Mar-Apr;28(2):624-9.
        doi: 10.1111/jvim.12322pubmed: 24611990google scholar: lookup